Last reviewed: May 29, 2026
Last updated: May 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Semaglutide significantly reduces appetite and food intake, which can deplete critical micronutrients including B12, folate, iron, and calcium. Studies show GLP-1 users require targeted supplementation to prevent deficiencies that may compromise energy, bone health, and metabolic function during treatment.
At PlexusDx, we emphasize precision wellness: understanding your individual nutritional vulnerabilities helps you work with your provider to create a supplementation plan aligned with your genetic predispositions and treatment goals, not generic recommendations.
Start a Semaglutide program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded Semaglutide, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start your intake →
How Semaglutide Affects Nutrient Absorption and Demand
Semaglutide slows gastric emptying and reduces overall caloric intake, limiting the total nutrient your body receives from food. Additionally, reduced stomach acid and altered intestinal transit can impair absorption of nutrients like B12 and iron, both critical for energy and oxygen transport.
Long-term GLP-1 therapy users report increased fatigue, weakness, and hair loss—common signs of B12, iron, or protein deficiency. Baseline nutrient levels and genetic factors affecting absorption pathways influence how quickly deficiencies develop and which micronutrients warrant priority supplementation.
Core Micronutrients and Evidence-Based Supplementation Guidelines
Research and clinical practice guidelines identify five micronutrients requiring particular attention during GLP-1 therapy. Understanding dosage ranges, timing, and biomarker indicators helps you and your provider create an effective supplementation strategy tailored to your baseline status.
| Micronutrient |
Why It Matters on Semaglutide |
Typical Dosing Range |
Monitoring Consideration |
| Vitamin B12 |
Reduced intrinsic factor and absorption; deficiency causes fatigue and neuropathy |
500–2,000 mcg monthly IM or 1,000–2,000 mcg daily oral |
Baseline serum B12; monitor annually |
| Folate (B9) |
Low intake from reduced food volume increases homocysteine risk |
400–800 mcg daily as methylfolate |
Baseline RBC folate; assess if history of anemia |
| Iron |
Reduced stomach acid impairs ferrous absorption; women at higher risk |
18–27 mg daily ferrous sulfate or bisglycinate form |
Baseline serum ferritin and TIBC; monitor if heavy periods |
| Calcium + Vitamin D |
GLP-1 reduces calcium-rich food intake and absorption; bone loss risk over 12+ months |
1,000–1,200 mg calcium; 1,000–2,000 IU vitamin D3 daily |
Baseline 25-OH vitamin D; consider DEXA if long-term therapy |
Genetic Predispositions and Individual Micronutrient Vulnerabilities
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
PlexusDx's Precision Peptide Genetic Test reveals predispositions in nutrient-metabolism pathways relevant to GLP-1 users. These insights may help guide conversations with your provider about whether higher baseline micronutrient screening or more aggressive supplementation timing is warranted before starting or optimizing your treatment.
Timing, Form, and Safety Considerations for Micronutrient Supplementation
Supplement timing and form matter significantly on semaglutide. B12 injections bypass absorption challenges; oral B12 requires intrinsic factor. Iron should be taken with vitamin C on an empty stomach for absorption but may cause nausea. Calcium and iron compete for absorption and must be spaced 2+ hours apart to maximize uptake.
Before starting supplementation, consult your healthcare provider about baseline micronutrient levels, drug interactions, and whether you have conditions (e.g., hemochromatosis, kidney disease) that alter supplementation safety. Your provider can order appropriate baseline biomarkers and recommend a schedule aligned with your semaglutide dosing and individual risk profile.
How PlexusDx Supports a More Personalized Approach
PlexusDx recognizes that nutritional demands during GLP-1 therapy are not one-size-fits-all. Genetic predispositions in nutrient-absorption pathways, metabolic efficiency, and even appetite regulation genes influence how semaglutide affects your micronutrient status. This context may help provide a more informed foundation for conversations with your provider about supplementation priorities.
The Precision Peptide Genetic Test examines variants in key metabolic pathways relevant to GLP-1 users, including genes affecting folate utilization, iron metabolism, and nutrient absorption efficiency. While the test does not predict exact micronutrient deficiency risk, it may help highlight genetic factors that inform whether aggressive screening or supplementation timing is appropriate for your situation.
Combining genetic insights with baseline biomarker data—serum B12, folate, iron, vitamin D, and calcium—enables a truly personalized supplementation plan. PlexusDx helps you understand your genetic predispositions so you can have a more informed conversation with your healthcare provider about micronutrient needs before, during, and after semaglutide therapy.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Oral is $349/mo month-to-month, or from $279/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Which micronutrients does the article's table single out for semaglutide users?
Four entries: vitamin B12, folate as B9, iron, and calcium paired with vitamin D. Each row gives a reason the nutrient is at risk on semaglutide, a dosing range, and a monitoring consideration. The article's premise is that a smaller total food volume means these are the nutrients most likely to fall short before anything else does.
Why does the post connect fatigue and hair loss to long-term GLP-1 use?
It describes increased fatigue, weakness and hair loss as commonly reported by long-term GLP-1 users and reads them as possible signs of B12, iron or protein deficiency. The article ties that back to reduced caloric intake plus altered intestinal transit, and says baseline nutrient levels influence how quickly any deficiency develops.
What baseline labs does the monitoring column pair with each nutrient?
Serum B12 for B12, red blood cell folate for folate, serum ferritin and TIBC for iron, and 25-hydroxy vitamin D for the calcium and vitamin D row. The table also suggests considering a DEXA scan for people on long-term therapy, and flags heavy periods and a history of anemia as reasons to look more closely.
Which conditions does the article say change whether supplementation is safe?
It names hemochromatosis and kidney disease as examples of conditions that alter supplementation safety, and says these should be raised with a provider before anything is started. The post also tells readers to ask about drug interactions and to have baseline micronutrient levels measured, rather than beginning a regimen based on the article's table alone.
Why does the post argue that form and timing matter, not just which nutrient?
Because absorption route changes the outcome. It notes that injectable B12 bypasses the absorption problem while oral B12 depends on intrinsic factor, and that iron and calcium compete for absorption rather than working in parallel. It also observes that iron taken for better absorption can provoke nausea, which matters more when a medication is already causing it.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic & Kidney Health: What Clinical Evidence Shows
Semaglutide Before Surgery: Safety Guidelines & Clinical Consi...